Chitosan-coated liposomes of Carrisa spinarum extract: synthesis, analysis and anti-pneumococcal potency
Creators
- 1. Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania, Global Health and Biomedical Sciences, Arusha, Tanzania
- 2. Kenya Medical Research Institute, Center for Traditional Medicine and Drug Research, Nairobi, Kenya
- 3. UNESCO, National Commission of the United Republic of Tanzania, Dar-es-salaam, Tanzania
- 4. DSI/Mintek Nanotechnology Innovation Centre – Biolabels Node, Department of Biotechnology, University of the Western Cape, Cape Town, South Africa
- 5. Infectious Diseases Nanomedicine Laboratory, Faculty of Natural Sciences, Department of Pharmaceutical Sciences, University of the Western CapeCape Town, South Africa
Description
In the present study, a chitosan (CS)-coated liposome (LipCsP-Chitosan) nanocarrier was fabricated for the delivery of Carissa spinarum (CsP) polyphenols to improve bioavailability and anti-pneumococcal potential against Klebsiella pneumoniae. LipCsP-Chitosan was synthesized by the ion gelation method and characterized by using a Malvern zetasizer and Fourier Transform Infrared (FTIR); CsP encapsulation and release kinetics were investigated. Anti-pneumococcal activity of the nanoformulations was accessed by agar-well diffusion and microdilution assays. LipCsP-chitosan exhibited a hydrodynamic size and zeta potential of 365.22 ± 0.70 nm and +39.30 ± 0.61 mV, respectively. CsP had an encapsulation efficiency of 81.5%. FTIR analysis revealed the interaction of the liposomes with chitosan and the CsP. A biphasic CsP release profile followed by a sustained release pattern was observed. LiPCsP-Chitosan presented a higher bioaccessibility of polyphenols in the simulated gastric phase (74.1% ± 1.3) than in the simulated intestinal phase (63.32% ± 1.00). LipCsP-chitosan had a relative inhibition zone diameter of 84.33% ± 2.51 when compared to CsP. At minimum inhibition concentration of 31.25 mg/mL, LipCsP-Chitosan reduced the viability of Klebsiella pneumoniae by 57.45% ± 3.76 after 24 h. The results obtained from the current study offer a new approach to the utilization of LipCsP-Chitosan as nanocarriers for candidate anti-pneumococcal agents.
Open Access
Licence Attribution (CC BY)
Publisher Website
Access full text
Publication Details
Journal article
Persistent Identifiers
DOI
10.1680/jbibn.22.00046
Read more